Search Results - "Ratanatharathorn, V."

Micafungin versus Fluconazole for Prophylaxis against Invasive Fungal Infections during Neutropenia in Patients Undergoing Hematopoietic Stem Cell Transplantation by van Burik, Jo-Anne H., Ratanatharathorn, Voravit, Stepan, Daniel E., Miller, Carole B., Lipton, Jeffrey H., Vesole, David H., Bunin, Nancy, Wall, Donna A., Hiemenz, John W., Satoi, Yoichi, Lee, Jeanette M., Walsh, Thomas J.

“…We hypothesized that chemoprophylaxis with the echinocandin micafungin would be an effective agent for antifungal prophylaxis during neutropenia in patients…”
Get full text

Age does not adversely influence outcomes among patients older than 60 years who undergo allogeneic hematopoietic stem cell transplant for AML and myelodysplastic syndrome by Modi, D, Deol, A, Kim, S, Ayash, L, Alavi, A, Ventimiglia, M, Bhutani, D, Ratanatharathorn, V, Uberti, J P

“…Allogeneic hematopoietic stem cell transplant (AHSCT) outcomes data of older AML/myelodysplastic syndrome (MDS) patients are limited. We retrospectively…”
Get full text

Clinical feasibility of TBI with helical tomotherapy by Peñagarícano, J A, Chao, M, Van Rhee, F, Moros, E G, Corry, P M, Ratanatharathorn, V

“…Our purpose was to present the clinical feasibility of TBI with helical tomotherapy (HT) in four patients with AML. Treatment planning, delivery, dose…”
Get full text

Long-term follow up of patients proceeding to transplant using plerixafor mobilized stem cells and incidence of secondary myelodysplastic syndrome/AML by Deol, A, Abrams, J, Masood, A, Al-Kadhimi, Z, Abidi, M H, Ayash, L, Lum, L G, Ratanatharathorn, V, Uberti, J P

“…We report the long-term follow up of 49 patients (pts) enrolled on plerixafor compassionate use protocol. Thirty-seven pts (76%) had failed one previous…”
Get full text

Modeling of carbon fiber couch attenuation properties with a commercial treatment planning system by Mihaylov, I. B., Corry, P., Yan, Y., Ratanatharathorn, V., Moros, E. G.

“…The purpose of this work is to evaluate the modeling of carbon fiber couch attenuation properties with a commercial treatment planning system (TPS, Pinnacle3,…”
Get full text

Chronic graft-versus-host disease: clinical manifestation and therapy by RATANATHARATHORN, V, AYASH, L, LAZARUS, H. M, FU, J, UBERTI, J. P

“…Chronic graft-versus-host disease (GVHD) is a major cause of morbidity and mortality in long-term survivors of allogeneic stem cell transplantation. The…”
Get full text

Low-dose antithymocyte globulin enhanced the efficacy of tacrolimus and mycophenolate for GVHD prophylaxis in recipients of unrelated SCT by Ratanatharathorn, V, Deol, A, Ayash, L, Cronin, S, Bhutani, D, Lum, L G, Abidi, M, Ventimiglia, M, Mellert, K, Uberti, J P

“…We performed a retrospective analysis of the outcome of 197 consecutive unrelated donor transplant recipients who received GVHD prophylaxis either TM regimen…”
Get full text

Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors by Nash, Richard A., Antin, Joseph H., Karanes, Chatchada, Fay, Joseph W., Avalos, Belinda R., Yeager, Andrew M., Przepiorka, Donna, Davies, Stella, Petersen, Finn B., Bartels, Pamela, Buell, Donald, Fitzsimmons, William, Anasetti, Claudio, Storb, Rainer, Ratanatharathorn, Voravit

“…After the transplantation of unmodified marrow from human leukocyte antigen-matched unrelated donors receiving cyclosporine (CSP) and methotrexate (MTX), the…”
Get full text

Large pericardial effusion as a complication in adults undergoing SCT by Norkin, M, Ratanatharathorn, V, Ayash, L, Abidi, M H, Al-Kadhimi, Z, Lum, L G, Uberti, J P

“…Large pericardial effusion (LPE) leading to cardiac tamponade is a rare complication described in patients undergoing SCT. This complication is considered to…”
Get full text

Low blood lymphocyte count at 30 days post transplant predicts worse acute GVHD and survival but not relapse in a large retrospective cohort by Gul, Z, Van Meter, E, Abidi, M, Ditah, I, Abdul-Hussein, M, Deol, A, Ayash, L, Lum, L G, Waller, E K, Ratanatharathorn, V, Uberti, J, Al-Kadhimi, Z

“…Multiple reports have shown that low absolute lymphocyte count at day 30 (ALC30) after allogeneic hematopoietic SCT (AHSCT) is associated with higher risk of…”
Get full text

SU‐E‐T‐154: Assessment of Monthly Linear Accelerator Beam Profile Constancy Based On AAPM TG‐142 Recommendations by Han, E, Gupta, S, Zhang, X, Hardee, M, Ratanatharathorn, V, Morrill, S

“…Purpose: AAPM Task Group 142 (TG‐142) gives new Quality Assurance (QA) recommendations for clinical linear accelerators to insure beam profile constancy. The…”
Get full text

SU‐E‐T‐439: First Experience of Three Dimensional Conformai Radiotherapy (3DCRT) Planning with Helical Tomotherapy by Chao, M, Corry, P, Zhang, X, Penagaricano, J, Ratanatharathorn, V

“…Purpose: A three‐dimensional conformal radiotherapy (3DCRT) has been recently introduced to helical tomotherapy, allowing the user to plan and treat patients…”
Get full text

Do negative or positive emotions differentially impact mortality after adult stem cell transplant? by HOODIN, F, UBERTI, J. P, LYNCH, T. J, STEELE, P, RATANATHARATHORN, V

“…Multiple diverse biomedical variables have been shown to affect outcome after hematopoietic stem cell transplantation (HSCT). Whether psychosocial variables…”
Get full text

Feasibility of TBI with Simultaneous Red Marrow Boost (rTMI) by Penagaricano, J.A, Moros, E.G, Corry, P.M, Ratanatharathorn, V

Get full text

Micafungin alone or in combination with other systemic antifungal therapies in hematopoietic stem cell transplant recipients with invasive aspergillosis by Kontoyiannis, D.P., Ratanatharathorn, V., Young, J.-A., Raymond, J., Laverdière, M., Denning, D.W., Patterson, T.F., Facklam, D., Kovanda, L., Arnold, L., Lau, W., Buell, D., Marr, K.A.

“…: We describe herein 98 hematopoietic stem cell transplant (HSCT) recipients with invasive aspergillosis (IA) (refractory in 83) who received micafungin either…”
Get full text

Nephrotic syndrome associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation by REDDY, P, JOHNSON, K, UBERTI, J. P, REYNOLDS, C, SILVER, S, AYASH, L, BRAUN, T. M, RATANATHARATHORN, V

“…Chronic graft-versus-host disease (cGVHD) is the most common late complication of allogeneic hematopoietic cell transplantation (HCT) causing significant…”
Get full text

SU‐E‐T‐324: Multi‐Institution Comparison for TrueBeam Commissioning Data and Beam Modeling Verification Using An Anisotropic Analytical Algorithm by Zhang, X, Gupta, S, Han, E, Morrill, S, Penagaricano, J, Liang, X, Sharma, S, Hardee, M, Ratanatharathorn, V

“…Purpose: To perform a dosimetric comparison of TrueBeam(TB) commissioning data between UAMS and other institutions; verify the beam modeling accuracy. Methods:…”
Get full text

SU‐E‐T‐204: Preliminary Study of the Comparison of Patient‐Specific QAs Using the Diode and Ionization Chamber Based Dosimetry Systems by Gupta, S, Zhang, X, Han, E, Liang, X, Sharma, S, Morrill, S, Hardee, M, Penagaricano, J, Ratanatharathorn, V

“…Purpose: Patient QA comparison by using the ArcCHECK diode cylindrical and PTW 2D ionization chamber array based dosimetry systems for in‐homogenous and small…”
Get full text

AOS23 O6-methylguanine-DNA-methyltransferase expression in Thai patients with malignant gliomas: Outcome and response to treatment in Ramathibodi Hospital by Akwattanakul, W, Larbcharoensub, N, Rattanasiri, S, Sirachainan, E, Panvichian, R, Ativitavas, T, Ratanatharathorn, V, Sirisinha, T

“…Background Malignant glioma is a rare but fatal tumour. High expression of O6-methylguanine-DNA-methyltransferase (MGMT) has been linked to poor outcome. We…”
Get full text

AOS17 KRAS genotypes in Thai patients with colorectal cancer by Autkittanon, P, Reukumneuychok, B, Limsuwanachot, N, Ativitavas, T, Sirisinha, T, Panvichian, R, Ratanatharathorn, V, Sirachainan, E

“…Background The reported prevalence of KRAS mutations, the predictive factor of efficacy of cetuximab in colorectal cancer, varies in 30–40% of patients…”
Get full text